Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS News Hour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Line. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
News Wrap: Supreme Court again rejects GOP push for new congressional map in Missouri
A look at the young conservative movement a year after Charlie Kirk's killing
Trump's vow of $5,000 payments to Americans faces bipartisan criticism
A Brief But Spectacular take on the toll of separation
George Pataki on how New York responded to 9/11 and its lasting impact
Iran-backed Houthis capture Red Sea port, putting more pressure on oil markets
Pentagon 9/11 survivor Kevin Shaeffer reflects on his escape: 'I had to fight'
September 10, 2026 - PBS News Hour full episode
AI researcher warns companies are ignoring catastrophic risks
The lasting psychological impact of 9/11 on America